Two Sigma Investments’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Buy |
4,110,852
+984,063
| +31% | +$3.38M | 0.03% | 654 |
|
|
2025
Q1 | $6.97M | Sell |
3,126,789
-130,522
| -4% | -$291K | 0.01% | 916 |
|
|
2024
Q4 | $9.54M | Buy |
3,257,311
+723,676
| +29% | +$2.12M | 0.02% | 729 |
|
|
2024
Q3 | $6.59M | Buy |
2,533,635
+472,279
| +23% | +$1.23M | 0.01% | 903 |
|
|
2024
Q2 | $6.1M | Buy |
2,061,356
+580,441
| +39% | +$1.72M | 0.01% | 870 |
|
|
2024
Q1 | $6.71M | Buy |
1,480,915
+411,677
| +39% | +$1.86M | 0.02% | 776 |
|
|
2023
Q4 | $6.11M | Sell |
1,069,238
-128,234
| -11% | -$732K | 0.01% | 828 |
|
|
2023
Q3 | $5.51M | Buy |
1,197,472
+134,292
| +13% | +$618K | 0.01% | 800 |
|
|
2023
Q2 | $6.87M | Buy |
1,063,180
+300,834
| +39% | +$1.94M | 0.02% | 746 |
|
|
2023
Q1 | $5.75M | Sell |
762,346
-198,366
| -21% | -$1.5M | 0.02% | 790 |
|
|
2022
Q4 | $9.73M | Sell |
960,712
-239,826
| -20% | -$2.43M | 0.03% | 543 |
|
|
2022
Q3 | $11.9M | Buy |
1,200,538
+472,616
| +65% | +$4.67M | 0.04% | 425 |
|
|
2022
Q2 | $7.75M | Buy |
727,922
+231,938
| +47% | +$2.47M | 0.03% | 577 |
|
|
2022
Q1 | $4.84M | Sell |
495,984
-19,616
| -4% | -$191K | 0.01% | 920 |
|
|
2021
Q4 | $7.37M | Buy |
515,600
+431,500
| +513% | +$6.17M | 0.02% | 757 |
|
|
2021
Q3 | $1.69M | Sell |
84,100
-293,116
| -78% | -$5.87M | ﹤0.01% | 1452 |
|
|
2021
Q2 | $8.3M | Buy |
377,216
+265,931
| +239% | +$5.85M | 0.02% | 718 |
|
|
2021
Q1 | $3.78M | Buy |
+111,285
| New | +$3.78M | 0.01% | 968 |
|